Novartis Investigative Site

Bernau 16321

0 studies enrolling now · 4 studies all time

What they study most

Adrenocortical Adenoma, Endometrial Stromal Sarcomas, Heart Failure With Reduced Ejection Fraction, Partial Onset Seizures

Studies at this site

• Phase II BGG492 Capsule Extension for Partial Epilepsy — Completed
• Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures — Completed
• Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early